Clovis Oncology
CLVS
#10431
Rank
A$16.44 M
Marketcap
A$0.11
Share price
0.00%
Change (1 day)
-95.62%
Change (1 year)

Earnings for Clovis Oncology (CLVS)

Earnings in 2022 (TTM): -A$0.32 Billion

According to Clovis Oncology's latest financial reports the company's current earnings are A$0.13 Billion. In 2021 the company made an earning of -A$0.33 Billion, an increase over its 2020 earnings that were of -A$0.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clovis Oncology from 2010 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -A$0.32 Billion-4.84%
2021 -A$0.33 Billion-32.64%
2020 -A$0.49 Billion-9.06%
2019 -A$0.54 Billion7.49%
2018 -A$0.5 Billion4.42%
2017 -A$0.48 Billion-8.83%
2016 -A$0.52 Billion-0.4%
2015 -A$0.53 Billion140.82%
2014 -A$0.22 Billion86.64%
2013 -A$0.12 Billion19.53%
2012 -A$97.16 Million
2010 -A$37.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.88 B-15,533.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$14.24 B-4,788.05%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$9.21 B-3,134.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$35.95 B-11,935.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$19.71 B-6,589.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
BioMarin Pharmaceutical
BMRN
A$0.67 B-321.93%๐Ÿ‡บ๐Ÿ‡ธ USA